AIHC Capital Management Ltd
Follow13F filer, CIK 2103725, CENTRAL, Hong Kong
AIHC Capital Management Ltd reported $106,710,558 across 6 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-05.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-26-000478
- Period
- 2025-12-31
- Reported value
- $107M
- Holdings
- 6
- Top 10 weight
- 100%
- New
- Sold out
Holdings, Q4 2025
Share positions as resolved from 13F-HR 0001172661-26-000478, largest first. % of portfolio is the value over $106,710,558, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| RVMDREVOLUTION MEDICINES INC | 900,392 | $71.7M | 67.21% | Timeline | |||
| PTGXPROTAGONIST THERAPEUTICS INC | 189,823 | $16.6M | 15.54% | Timeline | |||
| AVBPARRIVENT BIOPHARMA INC | 644,788 | $13M | 12.16% | Timeline | |||
| COGTCOGENT BIOSCIENCES INC | 100,000 | $3.55M | 3.33% | Timeline | |||
| NBPNOVABRIDGE BIOSCIENCES | 413,979 | $1.65M | 1.54% | Timeline | |||
| KRROKORRO BIO INC | 30,265 | $242K | 0.23% | Timeline |
How Q4 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001172661-26-000478 | base | 2026-02-05 | acceptance time not in the bulk data set |